This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
The HBR List: Breakthrough Ideas for 2010
Amabile, Teresa M.; Kramer, Steven J.; Dixon, Ronald , M.D.; Candell, Lawrence M.; Bonabeau, Eric; Bingham, Alpheus; Schacht, Aaron; Hidary, Jack D.; Litan, Robert E.; Mitchell, Lesa; Jensen, Bill; Klein, Josh; Mullainathan, Sendhil; Romer, Paul; Ross, CarneArticle HBS-R1001A-EHBR's annual ideas collection, compiled in cooperation with the World Economic Forum, offers 10 fresh solutions with the potential for a huge positive impact on business and the world. Teresa M. Amabile and Steven J. Kramer reveal what their research shows is the true key to employee motivation-and it's not what most managers focus on providing. Ronald Dixon proposes that the real performance breakthrough in health care will come when the medical...Starting at €8.20
-
La lista HBR: ideas innovadoras para 2010
Amabile, Teresa M.; Kramer, Steven J.; Dixon, Ronald , M.D.; Candell, Lawrence M.; Bonabeau, Eric; Bingham, Alpheus; Schacht, Aaron; Hidary, Jack D.; Litan, Robert E.; Mitchell, Lesa; Jensen, Bill; Klein, Josh; Mullainathan, Sendhil; Romer, Paul; Ross, CarneArticle HBS-R1001AKnowledge and CommunicationLa colección de HBR anual de las ideas, compilado en colaboración con el Foro Económico Mundial, ofrece 10 soluciones frescas con el potencial para un gran impacto positivo en los negocios y el mundo. Teresa M. Amabile y Steven J. Kramer revelan cuáles son sus demostraciones de la investigación es la verdadera clave para la motivación de los empleados y no es lo que la mayoría de los gerentes se centran en proporcionar. Ronald Dixon propone que e...Starting at €8.20
-
A More Rational Approach to New-Product Development
Bonabeau, Eric; Bodick, Neil; Armstrong, Robert W.Article HBS-R0803G-ECompanies often treat new-product development as a monolithic process, but it can be more rationally divided into two parts: an early stage that focuses on evaluating prospects and eliminating bad bets, and a late stage that maximizes the remaining candidates' market potential. Recognizing the value of this approach, Eli Lilly designed and piloted Chorus, an autonomous unit dedicated solely to the early stage. This article demonstrates how segmen...Starting at €8.20